You have 9 free searches left this month | for more free features.


Showing 1 - 25 of 965


Myeloid Leukemia, Acute Trial in France (Bone osteodensitometry)

Not yet recruiting
  • Myeloid Leukemia, Acute
  • Bone osteodensitometry
  • Amiens, France
  • +3 more
Dec 6, 2021

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in Beijing (Ex-vivo expanded ?d T cell infusion)

  • Acute Myeloid Leukemia
  • +3 more
  • Ex-vivo expanded γδ T cell infusion
  • Beijing, China
    Chinese PLA General Hospital
Mar 24, 2022

AML Trial in Moscow (allo-HSCT)

  • AML
  • allo-HSCT
  • Moscow, Russian Federation
    National Research Center for Hematology
Apr 14, 2022

PLT After Allogenic Hematopoietic Stem Cell Transplantation Trial (Avatrombopag, rhTPO)

Not yet recruiting
  • PLT After Allogenic Hematopoietic Stem Cell Transplantation
  • (no location specified)
Nov 21, 2021

Adult Acute Myeloid Leukemia Trial (mocravimod)

Not yet recruiting
  • Adult Acute Myeloid Leukemia
  • (no location specified)
Jun 27, 2022

Graft Vs Host Disease Trial in Beijing (UC-MSC, Anti-CD25 mAb)

Not yet recruiting
  • Graft Vs Host Disease
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Feb 1, 2021

Resolving Inflammaging Allo HSCT Survivors in Personal Training

  • Allogeneic HCT Survivors
  • 10 Weeks of Strength Trailing
  • Group Nutrition Discussion: week 1, week 5 and week 10
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Mar 31, 2022

Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome), Mucopolysaccharidosis Type IH, MPS IH, Hurler Syndrome Trial

Not yet recruiting
  • Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome)
  • +2 more
  • Autologous Plasmablasts
  • (no location specified)
Apr 4, 2022

Aplastic Anemia Trial in Suzhou (CD20 mAb, ATG)

  • Aplastic Anemia
  • CD20 monoclonal antibody
  • ATG
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 21, 2022

Relapse Rate After Allo-HSCT Trial in Shanghai (Flu-Bu-Mel)

Active, not recruiting
  • Relapse Rate After Allo-HSCT
  • Shanghai, China
  • +1 more
Jun 1, 2021

Acute Myeloid Leukemia, Allogeneic Hematopoietic Cell Transplantation Trial in Minneapolis (Fecal Microbiota Transplant (FMT),

Active, not recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Cell Transplantation
  • Fecal Microbiota Transplant (FMT)
  • Placebo
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Feb 16, 2022

Acute GVHD in Intestine Trial in Beijing, Jinan (Fecal Microbiota Transplantation, drug)

  • Acute Graft Versus Host Disease in Intestine
  • Fecal Microbiota Transplantation
  • drug
  • Beijing, Beijing, China
  • +1 more
Aug 30, 2021

Engraft Failure, Relapse, GVHD Trial (decitabine, Acetylcysteine, Semustine)

Not yet recruiting
  • Engraft Failure
  • +2 more
  • (no location specified)
Jun 22, 2021

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

  • Multiple Myeloma
  • Stem Cell Transplant
    • Firenze, Italy
    • +1 more
    Aug 19, 2021

    Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

    • Hematological Neoplasms
    • Recurrence
    • Peg interferon alfa-2b
    • Shanghai, Shanghai, China
      Shanghai Jiao Tong University Affilated First People's Hospital
    Oct 10, 2021

    Hematologic Malignancy Trial in Saint Petersburg (Prophylactic Donor lymphocytes infusions, Preventive Donor lymphocytes

    • Hematologic Malignancy
    • Prophylactic Donor lymphocytes infusions
    • Preventive Donor lymphocytes infusions
    • Saint Petersburg, Russian Federation
      RM Gorbacheva Research Institute
    Aug 16, 2021

    Irradiated Bone Marrow, Transplant-Related Hematologic Malignancy, Leukemia, Acute Trial in Milano (Conditioning treatment

    • Irradiated Bone Marrow
    • +4 more
    • Conditioning treatment "Treosulfan-TMI"
    • +2 more
    • Milano, Lombardia, Italy
      Ospedale San Raffaele
    Oct 13, 2020

    Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

    Active, not recruiting
    • Acute Myelogenous Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Feb 25, 2022

    GVHD, Acute Trial in Shanghai (PT-CY-FK +/-ATG)

    • GVHD, Acute
    • PT-CY-FK +/-ATG
    • Shanghai, Shanghai, China
      Rui Jin Hospital
    May 19, 2021

    Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an

    • Precursor Cell Lymphoblastic Leukemia-Lymphoma
    • +2 more
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xian Jiaotong University
    Sep 29, 2021

    Lymphoid Tumor Trial in Shanghai (Flu-Bu-Mel-E)

    • Lymphoid Neoplasm
    • Shanghai, China
      Blood & Marrow Transplantation Center, RuiJin Hospital
    May 22, 2021

    Leukemia, Acute Trial in New York (Allogeneic T cell progenitors, cultured ex-vivo)

    • Leukemia, Acute
    • Allogeneic T cell progenitors, cultured ex-vivo
    • New York, New York
      Memorial Sloan Kettering Cancer Center (MSKCC)
    Dec 9, 2021

    Donor CHIP and Allogeneic HSCT Outcome

    • Clonal Hematopoiesis
    • Next generation sequencing
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Dec 29, 2020

    Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

    • Myelodysplastic Syndrome
    • +2 more
    • Granulocyte Colony-Stimulating Factor(G-CSF)
    • +5 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Jul 11, 2022

    Epidermolysis Bullosa Trial in Minneapolis (drug, radiation, procedure, biological)

    • Epidermolysis Bullosa
    • Minneapolis, Minnesota
      University of Minnesota Masonic Cancer Center and Medical Center
    Jan 20, 2022